Pilot and Feasibility Studies (May 2020)

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Kimberly Legault,
Mark Blostein,
Marc Carrier,
Susan Kahn,
Sam Schulman,
Sudeep Shivakumar,
Cynthia Wu,
Mark A. Crowther

Affiliations

Kimberly Legault: Department of Medicine, McMaster University
Mark Blostein: Department of Medicine, McGill University
Marc Carrier: Department of Medicine, University of Ottawa
Susan Kahn: Department of Medicine, McGill University
Sam Schulman: Department of Medicine, McMaster University
Sudeep Shivakumar: Department of Medicine, Dalhousie University
Cynthia Wu: Department of Medicine, University of Alberta
Mark A. Crowther: Department of Medicine, McMaster University

DOI: https://doi.org/10.1186/s40814-020-00614-0
Journal volume & issue: Vol. 6, no. 1
pp. 1 – 1

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Published in Pilot and Feasibility Studies

ISSN: 2055-5784 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://pilotfeasibilitystudies.biomedcentral.com

About the journal